These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 743940)
1. [Schizophrenia and addiction]. Sizaret P; Degiovanni A; Barthelemy L Encephale; 1978; 4(4):349-63. PubMed ID: 743940 [TBL] [Abstract][Full Text] [Related]
2. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis]. Potvin S; Stip E; Roy JY Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543 [TBL] [Abstract][Full Text] [Related]
3. Biochemistry and the schizophrenia. Old concepts and new hypothesis. Berger PA J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786 [TBL] [Abstract][Full Text] [Related]
4. [Biochemistry of schizophrenia and mechanism of action of neuroleptics]. Loo H; Cuche H; Sechter D Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604 [TBL] [Abstract][Full Text] [Related]
5. [Findings of biochemical research on schizophrenia (author's transl)]. Ackenheil M; Hippius H; Matussek N Nervenarzt; 1978 Nov; 49(11):634-49. PubMed ID: 31575 [No Abstract] [Full Text] [Related]
6. The relationship between epilepsy and schizophrenia: a biochemical hypothesis. Trimble M Biol Psychiatry; 1977 Apr; 12(2):299-304. PubMed ID: 15665 [TBL] [Abstract][Full Text] [Related]
7. Does dopamine have a role in schizophrenia? Carlsson A Biol Psychiatry; 1978 Feb; 13(1):3-21. PubMed ID: 341997 [No Abstract] [Full Text] [Related]
8. [Neuroleptics and serotonin]. Hery F; Hamon M Encephale; 1993; 19(5):525-32. PubMed ID: 7905821 [TBL] [Abstract][Full Text] [Related]
9. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia. Haleem DJ J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192 [TBL] [Abstract][Full Text] [Related]
10. Biochemical aspects of schizophrenia. Lewis ME Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597 [No Abstract] [Full Text] [Related]
11. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826 [TBL] [Abstract][Full Text] [Related]
13. The treatment of schizophrenic psychoses with gamma-type endorphins. van Praag HM; Verhoeven WM; van Ree JM; de Wied D Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158 [TBL] [Abstract][Full Text] [Related]
14. [Current concepts of the effects of neuroleptics]. Kostowski W; Płaźnik A Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397 [No Abstract] [Full Text] [Related]
15. Drug abuse: a biopsychiatric model. Giannini AJ; Miller NS Am Fam Physician; 1989 Nov; 40(5):173-82. PubMed ID: 2573261 [TBL] [Abstract][Full Text] [Related]
19. [Alcohol and drug abuse as risk factors for violence and delinquency in schizophrenic patients]. Soyka M; Immler B; Sand P Psychiatr Prax; 1993 Sep; 20(5):172-5. PubMed ID: 8248441 [TBL] [Abstract][Full Text] [Related]
20. Biological research on drug abuse and addiction in Hispanics: current status and future directions. Trujillo KA; Castañeda E; Martínez D; González G Drug Alcohol Depend; 2006 Sep; 84 Suppl 1():S17-28. PubMed ID: 16777354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]